Free Trial
NASDAQ:NMRD

Nemaura Medical (NMRD) Stock Price, News & Analysis

Nemaura Medical logo
$0.0001 0.00 (-50.00%)
(As of 12/20/2024 10:56 AM ET)

About Nemaura Medical Stock (NASDAQ:NMRD)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
$0.00
$0.03
52-Week Range
$0.00
$0.25
Volume
1,000 shs
Average Volume
42,979 shs
Market Capitalization
$4,035.20
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Nemaura Medical Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
27th Percentile Overall Score

NMRD MarketRank™: 

Nemaura Medical scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Nemaura Medical.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nemaura Medical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nemaura Medical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for NMRD.
  • Dividend Yield

    Nemaura Medical does not currently pay a dividend.

  • Dividend Growth

    Nemaura Medical does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for NMRD.
  • News Sentiment

    Nemaura Medical has a news sentiment score of 1.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Nemaura Medical this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for NMRD on MarketBeat in the last 30 days.
  • MarketBeat Follows

    3 people have added Nemaura Medical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nemaura Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    40.42% of the stock of Nemaura Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 4.41% of the stock of Nemaura Medical is held by institutions.

  • Read more about Nemaura Medical's insider trading history.
Receive NMRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter.

NMRD Stock News Headlines

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Nemaura Medical Inc (NMRD)
NXNN Nexeon Medsystems Inc
See More Headlines

NMRD Stock Analysis - Frequently Asked Questions

Nemaura Medical's stock was trading at $0.2190 at the beginning of the year. Since then, NMRD shares have decreased by 100.0% and is now trading at $0.0001.
View the best growth stocks for 2024 here
.

Nemaura Medical Inc. (NASDAQ:NMRD) released its earnings results on Monday, February, 12th. The company reported ($0.12) EPS for the quarter.

Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nemaura Medical investors own include Ford Motor (F), Pfizer (PFE), Meta Platforms (META), Exxon Mobil (XOM), Agile Therapeutics (AGRX) and Tesla (TSLA).

Company Calendar

Last Earnings
2/12/2024
Today
12/22/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NMRD
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3,017.00
Book Value
($0.41) per share

Miscellaneous

Free Float
24,042,000
Market Cap
$4,035.20
Optionable
No Data
Beta
0.13
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:NMRD) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners